Sirio Pharma Co., Ltd. (SHE:300791)

China · Delayed Price · Currency is CNY

19.16

+0.04 (0.21%)

May 8, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Vitamins & Nutrition Products		3.58B	2.51B	2.37B	2.07B	1.58B
Vitamins & Nutrition Products Growth		42.87%	5.84%	14.62%	30.85%	-0.99%
Total		3.58B	2.51B	2.37B	2.07B	1.58B
Total Growth		42.87%	5.84%	14.62%	30.85%	-0.99%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		1.85B	1.49B	1.46B	1.28B	961.27M
China Growth		24.11%	2.28%	14.06%	32.99%	-4.26%
Americas		1.04B	540.90M	398.08M	265.76M	-
Americas Growth		93.04%	35.88%	49.79%	-	-
Europe		529.11M	395.52M	435.36M	461.58M	437.13M
Europe Growth		33.78%	-9.15%	-5.68%	5.59%	-3.44%
Other Areas		157.83M	79.48M	77.34M	61.06M	19.30M
Other Areas Growth		98.56%	2.78%	26.66%	216.42%	-32.23%
North America		-	-	-	-	161.86M
North America Growth		-	-	-	-	46.93%
Total		3.58B	2.51B	2.37B	2.07B	1.58B
Total Growth		42.87%	5.84%	14.62%	30.85%	-0.99%

Source: S&P Global Market Intelligence.